从植物到途径:通过计算和实验方法防止氨基酸-β聚合的鲁斯科根因分子机制
Aastha Tiwari1, Ravinder Singh2, Shubham Kumar1
1Department of Bioengineering and Biotechnology, Birla Institute of Technology Mesra, Ranchi, Jharkhand 835215, India.
ACS chemical neuroscience
|January 10, 2025
概括
作为一种天然化合物,ruscogenin有效地抑制了阿尔茨海默氏症患者的粉样β聚合.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 涉及粉样β (Aβ) 斑块和神经退行.
- 自然化合物正在探索AD的治疗潜力.
- 鲁斯科根因具有抗氧化和抗炎性质.
研究的目的:
- 调查ruscogenin在缓解阿尔茨海默病病理学的有效性.
- 探索ruscogenin对粉样β聚合的作用.
主要方法:
- 使用了分子对接和ADME选.
- 在体外测试中评估了ruscogenin对Aβ聚合的影响.
- 分子动力学模拟分析了ruscogenin与Aβ的相互作用.
主要成果:
- 鲁斯科根因表明抑制了Aβ寡合化.
- 分子动态学揭示了ruscogenin的目标是容易聚合的Aβ区域.
- 抑制依赖于度,表现出多相性行为.
结论:
- 鲁斯科根因作为阿尔茨海默病的天然治疗剂显示出前景.
- 鲁斯科根因治疗了与阿尔茨海默病相关的氧化应激和炎症.
- 对基于ruscogenin的干预措施的进一步研究是有必要的.
相关概念视频
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K